Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Gross Margin: 2022-2025

Historic Gross Margin for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -814.59%.

  • Abivax's Gross Margin fell 13909524.00% to -814.59% in Q2 2025 from the same period last year, while for Jun 2025 it was -764.95%, marking a year-over-year increase of 7036.00%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q2 2025, Abivax's Gross Margin stood at -814.59%, which was down 914.59% from 100.00% recorded in Q1 2025.
  • Over the past 5 years, Abivax's Gross Margin peaked at 138,280.65% during Q2 2024, and registered a low of -814.59% during Q2 2025.
  • For the 3-year period, Abivax's Gross Margin averaged around 22,977.68%, with its median value being 100.00% (2025).
  • Data for Abivax's Gross Margin shows a maximum YoY slumped of 13,909,524bps (in 2025) over the last 5 years.
  • Abivax's Gross Margin (Quarterly) stood at 100.00% in 2022, then remained steady at 100.00% in 2023, then remained steady at 100.00% in 2024, then tumbled by 13,909,524bps to -814.59% in 2025.
  • Its Gross Margin stands at -814.59% for Q2 2025, versus 100.00% for Q1 2025 and 100.00% for Q4 2024.